Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02255474 · ClinicalTrials.gov registry record · NA
Bifocal Lenses In Nearsighted Kids
A NA study, sponsored by Ohio State University.
- Completed
- Registry status
- NA
- Development phase
- 294
- Enrollment target
NCT02255474: Completed NA study, sponsored by Ohio State University.
NCT02255474 is a NA study that has completed, run by Ohio State University. The registered enrollment target is 294 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02255474, a NA study, has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 294 participants
- Enrollment target
Study Summary
This study will evaluate the use of two different bifocal contact lens add powers to prevent further nearsighted progression in children ages 7 to 11 years old. It is theorized that the profile of the bifocal lenses will decrease the amount of change in nearsightedness that the children experience.
Primary Outcome
Refractive error, as measured by cycloplegic autorefraction in both eyes, will be measured yearly to assess the difference in progression between the two soft bifocal treatment lenses (+1.50 D add and +2.50 D add) and the control group (soft spherical contact lenses).
Interventions
- DEVICE Biofinity Multifocal D +1.50 add
- DEVICE Biofinity Multifocal D +2.50 add
- DEVICE Biofinity
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 294 participants |
| Start Date | 2014-09-22 |
| Est. Completion | 2019-06-24 |
| Phase | NA |
What the finished NCT02255474 record still lists
NCT02255474 is an interventional study that assigns participants to a tested intervention. The registered 294 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower).
The record links to 0 conditions, and to 3 interventions - of which Biofinity Multifocal D +1.50 add is the first listed.
NCT02255474 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02255474 about?
NCT02255474 is a clinical study titled "Bifocal Lenses In Nearsighted Kids". This study will evaluate the use of two different bifocal contact lens add powers to prevent further nearsighted progression in children ages 7 to 11 years old. It is theorized that the profile of the bifocal lenses will decrease the amount of change in nearsightedness that the children experience.
What is the current status of trial NCT02255474?
This trial is currently completed. It is a NA study. The enrollment target is 294 participants. The study started on 2014-09-22. Estimated completion is 2019-06-24.
What interventions are being tested in trial NCT02255474?
The interventions under investigation include: Biofinity Multifocal D +1.50 add (DEVICE), Biofinity Multifocal D +2.50 add (DEVICE), Biofinity (DEVICE).
Who is sponsoring clinical trial NCT02255474?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02255474's enrollment target sits among peer trials
294 373rd of 2000 higher than 1,626 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05775159 · 294 participants · Phase 2
Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer
- NCT06262113 · 294 participants · NA
A Decentralized Clinical Trial to Promote Evidence-Based Care for Underserved Patients With Neurofibromatosis 1
- NCT06338865 · 294 participants · NA
Short Title: Standard vs. Lower Pressure Pneumoperitoneum
- NCT06395467 · 294 participants · NA
Integrated Treatment for Enhancing Growth in Recovery During Adolescence
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI